{"id":"https://genegraph.clinicalgenome.org/r/0315e84d-759c-489f-89b7-746209001a12v1.0","type":"EvidenceStrengthAssertion","dc:description":"RNASEH2C was first reported in relation to autosomal recessive Aicardi-Goutieres type 3 (OMIM: 610330) in 2006 (PMID: 16845400). RNASEH2C encodes ribonuclease H2 subunit C, which comprises 164 amino acids. RNASEH enzymes endolytically cleave ribonucleotides from RNA:DNA duplexes, which occur during DNA replication, transcription and translation. RNASEH2 has been proposed to function in the removal of lagging strand Okazaki fragment RNA primers during DNA replication, as well as in the excision of single ribonucleotides from DNA:DNA duplexes (PMIDs: 21177854, 16845400).\n\nThe described autosomal recessive RNASEH2C phenotype is considered to be a form of type 1 interferonopathy, which is defined as a condition in which increased type 1 interferon signaling leads to autoimmune and neurological disorders (MONDO: 0700258). These disorders are caused by variants in genes involved in nucleic acid metabolism, sensing, and the innate immune response. Individuals with biallelic variants in RNASEH2C can present with a range of symptoms of variable severity and age of onset, within the context of an autoimmune disease.\n\nAt least 16 unique variants (missense, splicing, nonsense, indel) have been reported across 15 probands in 7 publications (PMIDs: 31130681, 23322642, 35551623, 16845400, 31559893, 25604658, 24183309)  are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is thought to be loss of function. This gene-disease relationship is also supported by experimental evidence (model system studies, PMID: 22802351). Although the mouse phenotype was limited due to early embryonic lethality, cells obtained from knock-out mouse embryos demonstrated increased genomic ribonucleotide load consistent with the underlying disease mechanism for type 1 interferonopathy (PMID: 22802351). \n\nIn summary, there is definitive evidence supporting the relationship between RNASEH2C and autosomal recessive RNASEH2C-related type 1 interferonopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic setting, and has been upheld over time. This classification was approached by the ClinGen Leukodystrophy and Leukoencephalopathy GCEP on the meeting date July 10, 2024 (SOP Version 10). \n\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/0315e84d-759c-489f-89b7-746209001a12","GCISnapshot":"https://genegraph.clinicalgenome.org/r/9f65b554-f11e-41ff-8a6f-dcb5d8484122","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/9f65b554-f11e-41ff-8a6f-dcb5d8484122_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10107","date":"2024-08-26T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/9f65b554-f11e-41ff-8a6f-dcb5d8484122_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10107","date":"2024-08-27T00:27:07.896Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9f65b554-f11e-41ff-8a6f-dcb5d8484122_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6e427c93-a4fb-4cc1-9042-0e581fb2173d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/14b991b6-5655-4d47-885c-6b8afb609058","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/14b991b6-5655-4d47-885c-6b8afb609058_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31559893","allele":{"id":"https://genegraph.clinicalgenome.org/r/11636ecd-db6a-4050-91df-9caeb314a422","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032193.4(RNASEH2C):c.155T>G (p.Ile52Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381299153"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/35cba5cc-e695-4fa1-865d-ea2be2dfd3a4","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/35cba5cc-e695-4fa1-865d-ea2be2dfd3a4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31559893","allele":{"id":"https://genegraph.clinicalgenome.org/r/29432d98-76f4-4ad2-91c6-116b289d8c15","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032193.4(RNASEH2C):c.472C>G (p.His158Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381293732"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/6e427c93-a4fb-4cc1-9042-0e581fb2173d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31559893","rdfs:label":"Adang P59","allele":[{"id":"https://genegraph.clinicalgenome.org/r/11636ecd-db6a-4050-91df-9caeb314a422"},{"id":"https://genegraph.clinicalgenome.org/r/29432d98-76f4-4ad2-91c6-116b289d8c15"}],"ethnicity":{"id":"cg:UnknownEthnicity"},"phenotypes":"obo:HP_0000252","previousTesting":true,"previousTestingDescription":"Not provided","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/35cba5cc-e695-4fa1-865d-ea2be2dfd3a4_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/14b991b6-5655-4d47-885c-6b8afb609058_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/af5d3810-b1ef-45b1-ad2f-117eb3722515_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dbe71e47-e75c-4862-9ad9-972c9286c48d","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dbe71e47-e75c-4862-9ad9-972c9286c48d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24183309","allele":{"id":"https://genegraph.clinicalgenome.org/r/58a887b5-9bc8-4052-bb75-695c7c573e20","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032193.4(RNASEH2C):c.38G>A (p.Arg13His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA224000270"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/af5d3810-b1ef-45b1-ad2f-117eb3722515","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24183309","rdfs:label":"AGS368","allele":{"id":"https://genegraph.clinicalgenome.org/r/58a887b5-9bc8-4052-bb75-695c7c573e20"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"previousTesting":true,"previousTestingDescription":"Not provided","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/dbe71e47-e75c-4862-9ad9-972c9286c48d_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/44e8b2fa-4df4-4d2d-88f0-cb0646374148_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b6996f8-8e4c-4e20-8f10-9f93a6fac53e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b6996f8-8e4c-4e20-8f10-9f93a6fac53e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35551623","allele":{"id":"https://genegraph.clinicalgenome.org/r/c3003d5f-6a9f-45b1-bf5d-88b03380d8ff","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032193.4(RNASEH2C):c.461C>T (p.Ala154Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6107683"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/78c0b8e9-cf52-469b-ba18-9bce0507b6d6","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/78c0b8e9-cf52-469b-ba18-9bce0507b6d6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35551623","allele":{"id":"https://genegraph.clinicalgenome.org/r/d0e326dd-8067-4e75-950d-27de28a1566c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032193.4(RNASEH2C):c.197G>A (p.Arg66His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381299026"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/44e8b2fa-4df4-4d2d-88f0-cb0646374148","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35551623","rdfs:label":"Wang_P13","allele":[{"id":"https://genegraph.clinicalgenome.org/r/d0e326dd-8067-4e75-950d-27de28a1566c"},{"id":"https://genegraph.clinicalgenome.org/r/c3003d5f-6a9f-45b1-bf5d-88b03380d8ff"}],"ethnicity":{"id":"cg:NotHispanicOrLatino"},"previousTesting":true,"previousTestingDescription":"Not provided.","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/9b6996f8-8e4c-4e20-8f10-9f93a6fac53e_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/78c0b8e9-cf52-469b-ba18-9bce0507b6d6_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/424bcd9d-e436-4fc4-833e-c97e2f3a1efe_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/172d8611-ead3-4c4d-af58-ce3e7658e6ba","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/172d8611-ead3-4c4d-af58-ce3e7658e6ba_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant has moderate functional evidence supporting abnormal protein function. This variant causes a decrease in RNase enzyme activity and stability (PMIDs: 19015152, 31529068).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/172d8611-ead3-4c4d-af58-ce3e7658e6ba_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24183309","allele":{"id":"https://genegraph.clinicalgenome.org/r/ce2c1ef9-612f-466e-b197-b1af217e89e2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032193.4(RNASEH2C):c.205C>T (p.Arg69Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA251720"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/424bcd9d-e436-4fc4-833e-c97e2f3a1efe","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24183309","rdfs:label":"AGS037","allele":{"id":"https://genegraph.clinicalgenome.org/r/ce2c1ef9-612f-466e-b197-b1af217e89e2"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"previousTesting":true,"previousTestingDescription":"Not provided","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/172d8611-ead3-4c4d-af58-ce3e7658e6ba_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/3ecd3264-29e3-4431-bed2-008dbd2bfb83_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe8199b2-1d46-4592-aa0f-23a3335efa2c","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe8199b2-1d46-4592-aa0f-23a3335efa2c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25604658","allele":{"id":"https://genegraph.clinicalgenome.org/r/11b32b09-64ae-4e05-8d43-7ea04f1169c5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032193.4(RNASEH2C):c.401T>C (p.Leu134Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381297819"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/3ecd3264-29e3-4431-bed2-008dbd2bfb83","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25604658","rdfs:label":"Proband 7","allele":{"id":"https://genegraph.clinicalgenome.org/r/11b32b09-64ae-4e05-8d43-7ea04f1169c5"},"previousTesting":true,"previousTestingDescription":"Not provided","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/fe8199b2-1d46-4592-aa0f-23a3335efa2c_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/930e5706-59fd-42a3-99fd-9805aec90728_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ca36288b-eb44-4448-95ba-faee966f63eb","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ca36288b-eb44-4448-95ba-faee966f63eb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 21177854 - Authors performed enzyme activity assays revealing that K143I had a pronounced effect on enzyme activity with an 85% reduction in specific activity. Measurement of enzyme kinetics for RNase H2 with K143I indicated decreased enzyme activity due to reduced turnover rather than reduced substrate affinity. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ca36288b-eb44-4448-95ba-faee966f63eb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16845400","allele":{"id":"https://genegraph.clinicalgenome.org/r/9a4aaa49-190d-4294-9c16-ac489ca71225","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032193.4(RNASEH2C):c.428A>T (p.Lys143Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA251722"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/930e5706-59fd-42a3-99fd-9805aec90728","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16845400","rdfs:label":"Crow F35","allele":{"id":"https://genegraph.clinicalgenome.org/r/9a4aaa49-190d-4294-9c16-ac489ca71225"},"detectionMethod":"Families in study underwent genome-wide homozygosity mapping together with subsequent microsatellite genotyping. AGS3 critical region refined and patients were sequenced for RNASEH2C. ","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Homozygosity mapping","previousTesting":false,"secondTestingMethod":"Genotyping","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/ca36288b-eb44-4448-95ba-faee966f63eb_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/170506c9-d551-4fd1-b62d-5ff498c54455_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3d530b86-fbc8-42d7-a98e-eed504081700","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3d530b86-fbc8-42d7-a98e-eed504081700_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25604658","allele":{"id":"https://genegraph.clinicalgenome.org/r/7fcefbcc-b8ef-4b2c-97a6-c4d34f38f78a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032193.4(RNASEH2C):c.215_218delinsTGGC (p.Glu72_Val73delinsValAla)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695214787"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/170506c9-d551-4fd1-b62d-5ff498c54455","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25604658","rdfs:label":"Proband 12","allele":{"id":"https://genegraph.clinicalgenome.org/r/7fcefbcc-b8ef-4b2c-97a6-c4d34f38f78a"},"ethnicity":{"id":"cg:UnknownEthnicity"},"previousTesting":true,"previousTestingDescription":"Not provided","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/3d530b86-fbc8-42d7-a98e-eed504081700_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/d99d0cee-09b3-4c99-8cda-526e362f20b0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/36554c82-872d-4eca-addb-94d845df1503","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/36554c82-872d-4eca-addb-94d845df1503_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant has moderate functional evidence supporting abnormal protein function. This variant causes a decrease in RNase enzyme activity and stability (PMIDs: 19015152, 31529068)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/36554c82-872d-4eca-addb-94d845df1503_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24183309","allele":{"id":"https://genegraph.clinicalgenome.org/r/ce2c1ef9-612f-466e-b197-b1af217e89e2"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/d99d0cee-09b3-4c99-8cda-526e362f20b0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24183309","rdfs:label":"AGS548","allele":{"id":"https://genegraph.clinicalgenome.org/r/ce2c1ef9-612f-466e-b197-b1af217e89e2"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"previousTesting":true,"previousTestingDescription":"Not provided","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/36554c82-872d-4eca-addb-94d845df1503_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/bd09dbd6-6d02-40bd-8021-770105fa516f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2dcd036a-f674-41a1-9a40-b129c7f75182","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2dcd036a-f674-41a1-9a40-b129c7f75182_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant has moderate functional evidence supporting abnormal protein function. This variant causes a decrease in RNase enzyme activity and stability (PMIDs: 19015152, 31529068).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2dcd036a-f674-41a1-9a40-b129c7f75182_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23322642","allele":{"id":"https://genegraph.clinicalgenome.org/r/ce2c1ef9-612f-466e-b197-b1af217e89e2"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/bd09dbd6-6d02-40bd-8021-770105fa516f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23322642","rdfs:label":"Vogt Patient 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/ce2c1ef9-612f-466e-b197-b1af217e89e2"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"phenotypeFreeText":"Roving eye movements, global cerebral atrophy, white matter abnormalities, thinning of the corpus callosum. ","phenotypes":["obo:HP_0001332","obo:HP_0000737","obo:HP_0000666","obo:HP_0012448","obo:HP_0032988"],"previousTesting":true,"previousTestingDescription":"Unknown","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/2dcd036a-f674-41a1-9a40-b129c7f75182_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/8e42c483-84aa-4ca6-9ad5-949eda6befc8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f6d6dd73-4fa3-4bc7-aa35-5e1a88c04676","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f6d6dd73-4fa3-4bc7-aa35-5e1a88c04676_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35551623","allele":{"id":"https://genegraph.clinicalgenome.org/r/f67353a5-f6d9-4615-8484-81eaa5175c90","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032193.4(RNASEH2C):c.194G>A (p.Gly65Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6107772"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d3c2e976-19fa-46a8-bef7-8b60855074ba","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d3c2e976-19fa-46a8-bef7-8b60855074ba_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID 21177854 - Authors performed flourescence-based thermal shift assay demonstrating that P76L leads to destabilization of the RNase H2 heterodimer.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d3c2e976-19fa-46a8-bef7-8b60855074ba_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35551623","allele":{"id":"https://genegraph.clinicalgenome.org/r/5cf831d8-b2a4-48e1-ae4c-920fc3136f36","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032193.4(RNASEH2C):c.227C>T (p.Pro76Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6107764"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8e42c483-84aa-4ca6-9ad5-949eda6befc8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35551623","rdfs:label":"Wang_P12","allele":[{"id":"https://genegraph.clinicalgenome.org/r/f67353a5-f6d9-4615-8484-81eaa5175c90"},{"id":"https://genegraph.clinicalgenome.org/r/5cf831d8-b2a4-48e1-ae4c-920fc3136f36"}],"ethnicity":{"id":"cg:NotHispanicOrLatino"},"previousTesting":true,"previousTestingDescription":"Not provided","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/f6d6dd73-4fa3-4bc7-aa35-5e1a88c04676_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/d3c2e976-19fa-46a8-bef7-8b60855074ba_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/62c5b1c8-699a-4a28-affe-4e36150bf3bd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/482e96bd-4bc6-4b6e-baea-7e2bc095a231","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/482e96bd-4bc6-4b6e-baea-7e2bc095a231_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant has moderate functional evidence supporting abnormal protein function. This variant causes a decrease in RNase enzyme activity and stability (PMIDs: 19015152, 31529068).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/482e96bd-4bc6-4b6e-baea-7e2bc095a231_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16845400","allele":{"id":"https://genegraph.clinicalgenome.org/r/ce2c1ef9-612f-466e-b197-b1af217e89e2"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/62c5b1c8-699a-4a28-affe-4e36150bf3bd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16845400","rdfs:label":"Crow F30","allele":{"id":"https://genegraph.clinicalgenome.org/r/ce2c1ef9-612f-466e-b197-b1af217e89e2"},"detectionMethod":"Families in study underwent genome-wide homozygosity mapping together with subsequent microsatellite genotyping. AGS3 critical region refined and patients were sequenced for RNASEH2C. ","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Homozygosity mapping","previousTesting":false,"secondTestingMethod":"Genotyping","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/482e96bd-4bc6-4b6e-baea-7e2bc095a231_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/9f65b554-f11e-41ff-8a6f-dcb5d8484122_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd809546-e8eb-4e57-84d6-721ea4e06eb7_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23322642","rdfs:label":"Vogt","estimatedLodScore":0.98,"family":{"id":"https://genegraph.clinicalgenome.org/r/cd809546-e8eb-4e57-84d6-721ea4e06eb7","type":"Family","rdfs:label":"Vogt","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/bd09dbd6-6d02-40bd-8021-770105fa516f"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/bd09dbd6-6d02-40bd-8021-770105fa516f"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/3115b464-076c-49cc-9297-9f84f1267611_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1085e166-7d65-4d42-a9e2-8938277593c2","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1085e166-7d65-4d42-a9e2-8938277593c2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31130681","allele":{"id":"https://genegraph.clinicalgenome.org/r/2b92bba4-78b2-4e66-a9ba-8ceaaccebe4f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032193.4(RNASEH2C):c.115G>T (p.Asp39Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6107826"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f6feb2bb-5b91-4400-a806-02f2d1494c91","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f6feb2bb-5b91-4400-a806-02f2d1494c91_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31130681","allele":{"id":"https://genegraph.clinicalgenome.org/r/2a73f0e9-166a-463e-91ff-8817ec7446a0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032193.4(RNASEH2C):c.173-1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381299073"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3115b464-076c-49cc-9297-9f84f1267611","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31130681","rdfs:label":"Garau_P37","allele":[{"id":"https://genegraph.clinicalgenome.org/r/2a73f0e9-166a-463e-91ff-8817ec7446a0"},{"id":"https://genegraph.clinicalgenome.org/r/2b92bba4-78b2-4e66-a9ba-8ceaaccebe4f"}],"detectionMethod":"NGS panel included 8 genes previously associated with type 1-interferonopathy. All identified variants were confirmed with Sanger sequencing.","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Spastic-dystonic tetraparesis","phenotypes":"obo:HP_0009710","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/f6feb2bb-5b91-4400-a806-02f2d1494c91_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/1085e166-7d65-4d42-a9e2-8938277593c2_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/65865c0d-8a3b-46b8-b3a7-d36461e8e2e1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db21568b-e1b1-4450-99ae-d621ac88866f","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db21568b-e1b1-4450-99ae-d621ac88866f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 21177854 - Authors performed enzyme activity assays revealing that K143I had a pronounced effect on enzyme activity with an 85% reduction in specific activity. Measurement of enzyme kinetics for RNase H2 with K143I indicated decreased enzyme activity due to reduced turnover rather than reduced substrate affinity. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/db21568b-e1b1-4450-99ae-d621ac88866f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25604658","allele":{"id":"https://genegraph.clinicalgenome.org/r/9a4aaa49-190d-4294-9c16-ac489ca71225"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/65865c0d-8a3b-46b8-b3a7-d36461e8e2e1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25604658","rdfs:label":"Proband 9","allele":{"id":"https://genegraph.clinicalgenome.org/r/9a4aaa49-190d-4294-9c16-ac489ca71225"},"previousTesting":true,"previousTestingDescription":"Not provided","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/db21568b-e1b1-4450-99ae-d621ac88866f_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/22ea3bc9-1c4d-4dc5-999b-5d74b2025b65_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9dc22dc7-36ad-4604-acd6-1820c3aafda6","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9dc22dc7-36ad-4604-acd6-1820c3aafda6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31559893","allele":{"id":"https://genegraph.clinicalgenome.org/r/98cdee9b-0eca-4a08-93b3-c0537a9f1f74","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032193.4(RNASEH2C):c.451C>T (p.Pro151Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6107686"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/75f3393c-4f25-45ba-9402-5a0675aeff18","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/75f3393c-4f25-45ba-9402-5a0675aeff18_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31559893","allele":{"id":"https://genegraph.clinicalgenome.org/r/e7fe331d-3950-4571-bd74-bed3bdb1cd28","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032193.4(RNASEH2C):c.450G>A (p.Trp150Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16619372"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/22ea3bc9-1c4d-4dc5-999b-5d74b2025b65","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31559893","rdfs:label":"Adang P58","allele":[{"id":"https://genegraph.clinicalgenome.org/r/98cdee9b-0eca-4a08-93b3-c0537a9f1f74"},{"id":"https://genegraph.clinicalgenome.org/r/e7fe331d-3950-4571-bd74-bed3bdb1cd28"}],"ethnicity":{"id":"cg:UnknownEthnicity"},"phenotypes":"obo:HP_0000252","previousTesting":true,"previousTestingDescription":"Not provided","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/75f3393c-4f25-45ba-9402-5a0675aeff18_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/9dc22dc7-36ad-4604-acd6-1820c3aafda6_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/c3405fde-38bc-45d5-b72e-34decc0cefb4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/937f221f-692a-4f17-99f9-9b38ddc3affd","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/937f221f-692a-4f17-99f9-9b38ddc3affd_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 21177854 - “All seven AGS mutations caused reduced thermal stability of recombinant RNase H2 complex compared with wild-type RNase H2 (Fig. 4C). Furthermore, with the exception of RNASEH2B:A177T and RNASEH2C: P138L, mutations reduced cleavage of RNA/DNA hybrids (Fig. 4D and data not shown).”","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/937f221f-692a-4f17-99f9-9b38ddc3affd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24183309","allele":{"id":"https://genegraph.clinicalgenome.org/r/98cdee9b-0eca-4a08-93b3-c0537a9f1f74"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9dfda4a0-bcf7-46f0-8446-d56393aa0de2","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9dfda4a0-bcf7-46f0-8446-d56393aa0de2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24183309","allele":{"id":"https://genegraph.clinicalgenome.org/r/0186962d-6ecc-4e75-83fe-95158fce2206","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032193.4(RNASEH2C):c.98C>G (p.Pro33Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381299388"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c3405fde-38bc-45d5-b72e-34decc0cefb4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24183309","rdfs:label":"AGS255","allele":[{"id":"https://genegraph.clinicalgenome.org/r/0186962d-6ecc-4e75-83fe-95158fce2206"},{"id":"https://genegraph.clinicalgenome.org/r/98cdee9b-0eca-4a08-93b3-c0537a9f1f74"}],"ethnicity":{"id":"cg:UnknownEthnicity"},"previousTesting":true,"previousTestingDescription":"Not provided","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/937f221f-692a-4f17-99f9-9b38ddc3affd_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/9dfda4a0-bcf7-46f0-8446-d56393aa0de2_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":11.4},{"id":"https://genegraph.clinicalgenome.org/r/9f65b554-f11e-41ff-8a6f-dcb5d8484122_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9f65b554-f11e-41ff-8a6f-dcb5d8484122_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4b72a42b-d490-4efa-9e90-dd3dc9284146","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ecce67d6-39cb-4864-83bc-c0ac6ac1e3f0","type":"Finding","dc:description":"Although mouse phenotype was limited for knock-out model due to early embryonic lethality, cells obtained from knock-out mouse embryos demonstrated increased genomic ribonucleotide load consistent with underlying disease mechanism. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22802351","rdfs:label":"Rnaseh2c-/- mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2}],"evidenceStrength":"Definitive","sequence":8879,"specifiedBy":"GeneValidityCriteria10","strengthScore":13.4,"subject":{"id":"https://genegraph.clinicalgenome.org/r/p2Gyy9uOhZI","type":"GeneValidityProposition","disease":"obo:MONDO_0700258","gene":"hgnc:24116","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_9f65b554-f11e-41ff-8a6f-dcb5d8484122-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}